A study led by University of Arkansas for Medical Sciences surgeon Brendan Stack has shown the potential to alter neck dissection surgeries in about 21 percent of head and neck cancer patients.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
